Get started
Walgreens Boots Alliance, Inc.Walgreens Boots Alliance, Inc.Walgreens Boots Alliance, Inc.

Walgreens Boots Alliance, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Options Bonds

WBA chart


Full chart

Key facts today

Walgreens Boots Alliance, Inc. settled for $100 million over claims of misleading generic drug pricing. UBS raised its price target from $9 to $10, while Morgan Stanley cut its target from $9 to $7.
Walgreens was one of the worst S&P 500 performers this year, raising concerns about possible tax-loss selling. CVS Health also faces challenges, suggesting it may encounter similar selling pressures.
Analyze the impactAnalyze the impact

WBA upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪7.17 B‬ USD
Dividend yield (indicated)
12.06%
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−10.01 USD
Net income (FY)
‪−8.64 B‬ USD
Revenue (FY)
‪147.66 B‬ USD
Shares float
‪710.05 M‬
Beta (1Y)
0.80

Employees


Employees (FY)
‪312 K‬
Change (1Y)
‪−19 K‬ −5.74%
Revenue / Employee (1Y)
‪473.26 K‬ USD
Net income / Employee (1Y)
‪−27.68 K‬ USD

About Walgreens Boots Alliance, Inc.


Sector
Retail Trade
Industry
Drugstore Chains
CEO
Timothy C. Wentworth
Website
walgreensbootsalliance.com
Headquarters
Deerfield
Founded
1909
FIGI
BBG000BWLMJ4
Walgreens Boots Alliance, Inc. engages in the provision of healthcare and retail pharmacy services. It operates through the following segments: United States Retail Pharmacy, International, and United States Healthcare. The US Retail Pharmacy segment includes the operation of retail drugstores, health and wellness services, specialty and home delivery pharmacy services, and equity method investment. The International segment offers pharmacy-led health and beauty retail businesses outside the US and the pharmaceutical wholesaling and distribution business in Germany. The US Healthcare segment delivers improved health outcomes and lower costs for payors and providers through owned and partnered assets. The company was founded by Charles R. Walgreen and John Boot in 1909 and is headquartered in Deerfield, IL.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

WBA news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

WBA highest yielding bonds


WAG5869718
Walgreens Boots Alliance, Inc. 8.125% 15-AUG-2029
Yield to maturity
8.33%
Maturity date
Aug 15, 2029
W
WAG3900832
Walgreen Co. 4.4% 15-SEP-2042
Yield to maturity
7.93%
Maturity date
Sep 15, 2042
W8AJ
WALGREENS BO. A. 16/46
Yield to maturity
7.72%
Maturity date
Jun 1, 2046
WAG4976357
Walgreens Boots Alliance, Inc. 3.2% 15-APR-2030
Yield to maturity
7.65%
Maturity date
Apr 15, 2030
WAG4182648
Walgreens Boots Alliance, Inc. 4.5% 18-NOV-2034
Yield to maturity
7.62%
Maturity date
Nov 18, 2034
WAG4182650
Walgreens Boots Alliance, Inc. 4.8% 18-NOV-2044
Yield to maturity
7.28%
Maturity date
Nov 18, 2044
WAG4976358
Walgreens Boots Alliance, Inc. 4.1% 15-APR-2050
Yield to maturity
6.66%
Maturity date
Apr 15, 2050
W8AH
WALGREENS BO. A. 16/26
Yield to maturity
5.87%
Maturity date
Jun 1, 2026
W8AG
WALGREENS BO. A. 14/26
Yield to maturity
5.16%
Maturity date
Nov 20, 2026

Explore more bonds 

Sparks


Curated watchlists where WBA is featured.

See all sparks 

Frequently Asked Questions


The current price of WBA is 8.24 USD — it has decreased by −0.30% in the past 24 hours. Watch Walgreens Boots Alliance, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Walgreens Boots Alliance, Inc. stocks are traded under the ticker WBA.
WBA stock has fallen by −8.47% compared to the previous week, the month change is a −23.33% fall, over the last year Walgreens Boots Alliance, Inc. has showed a −60.67% decrease.
We've gathered analysts' opinions on Walgreens Boots Alliance, Inc. future price: according to them, WBA price has a max estimate of 15.00 USD and a min estimate of 7.00 USD. Watch WBA chart and read a more detailed Walgreens Boots Alliance, Inc. stock forecast: see what analysts think of Walgreens Boots Alliance, Inc. and suggest that you do with its stocks.
WBA reached its all-time high on Aug 5, 2015 with the price of 97.30 USD, and its all-time low was 0.07 USD and was reached on Dec 9, 1974. View more price dynamics on WBA chart.
See other stocks reaching their highest and lowest prices.
WBA stock is 2.71% volatile and has beta coefficient of 0.80. Track Walgreens Boots Alliance, Inc. stock price on the chart and check out the list of the most volatile stocks — is Walgreens Boots Alliance, Inc. there?
Today Walgreens Boots Alliance, Inc. has the market capitalization of ‪7.17 B‬, it has decreased by −2.38% over the last week.
Yes, you can track Walgreens Boots Alliance, Inc. financials in yearly and quarterly reports right on TradingView.
Walgreens Boots Alliance, Inc. is going to release the next earnings report on Jan 2, 2025. Keep track of upcoming events with our Earnings Calendar.
WBA earnings for the last quarter are 0.39 USD per share, whereas the estimation was 0.36 USD resulting in a 8.85% surprise. The estimated earnings for the next quarter are 0.39 USD per share. See more details about Walgreens Boots Alliance, Inc. earnings.
Walgreens Boots Alliance, Inc. revenue for the last quarter amounts to ‪37.55 B‬ USD, despite the estimated figure of ‪35.75 B‬ USD. In the next quarter, revenue is expected to reach ‪37.39 B‬ USD.
WBA net income for the last quarter is ‪−3.00 B‬ USD, while the quarter before that showed ‪344.00 M‬ USD of net income which accounts for −973.55% change. Track more Walgreens Boots Alliance, Inc. financial stats to get the full picture.
Yes, WBA dividends are paid quarterly. The last dividend per share was 0.25 USD. As of today, Dividend Yield (TTM)% is 14.84%. Tracking Walgreens Boots Alliance, Inc. dividends might help you take more informed decisions.
As of Nov 21, 2024, the company has ‪312.00 K‬ employees. See our rating of the largest employees — is Walgreens Boots Alliance, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Walgreens Boots Alliance, Inc. EBITDA is ‪4.24 B‬ USD, and current EBITDA margin is 2.87%. See more stats in Walgreens Boots Alliance, Inc. financial statements.
Like other stocks, WBA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Walgreens Boots Alliance, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Walgreens Boots Alliance, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Walgreens Boots Alliance, Inc. stock shows the sell signal. See more of Walgreens Boots Alliance, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.